Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
Provided By GlobeNewswire
Last update: Nov 12, 2024
Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic pancreatic ductal adenocarcinoma
Read more at globenewswire.com
